Indoleamine 2, 3-dioxygenasase (IDO) as a prognostic factor of hematological malignancies

Takeshi Hara

Presentation information

Oral Session

Oral Session 1-8C Malignant Lymphoma: Prognostic factors

Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Takashi Watanabe (Department of Immuno-Gene Therapy Mie University Graduate School of Medicine, Japan)

[OS1-8C-3] Indoleamine 2, 3-dioxygenasase (IDO) as a prognostic factor of hematological malignancies

Takeshi Hara^1,2, Yuhei Shibata², Ryoko Mabuchi², Takuro Matsumoto², Nobuhiko Nakamura², Hiroshi Nakamura², Soranobu Ninomiya², Junichi Kitagawa², Nobuhiro Kanemura², Kenji Fukuno², Hisashi Tsurumi^1,2 (1.Dept. Hematol., Matsunami General Hosp., Gifu, Japan, 2.Dept. Hematol., Gifu Univ., Gifu, Japan)

Abstract password authentication.
Password is written on a program and abstract book.